Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome

Share this content:
Phase I/II Trial of Sodium Stibogluconate in Myelodysplastic Syndrome
 
Sponsors and Collaborators
Northwestern University
Robert H. Lurie Cancer Center
 
Contact
Elizabeth Eklund, MD
312-503-4625
 
Study Coordinator
312-695-1301
 
Investigator
Elizabeth Eklund, MD
Northwestern University
 
ClinicalTrials.gov Identifier

Related Resources

You must be a registered member of Cancer Therapy Advisor to post a comment.

Sign Up for Free e-newsletters



Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Prostate Cancer Regimens Drugs
Rare Cancers Regimens
Renal Cell Carcinoma Regimens Drugs
Skin Cancer Regimens Drugs
Urologic Cancers Regimens Drugs